The European Centre for Disease Prevention and Control (ECDC) has rated risk to children in Europe as being low overall, based on a very low likelihood of a child developing this high impact disease. Regarding ethnicity, the condition seems to affect more children of African, Afro-Caribbean, and Hispanic descent, whereas Kawasaki disease affects more of East Asian ancestry. Initial reports regarded children in various parts of Europe and the United States, and it was unclear to what extent the condition had gone unrecognized elsewhere. Reports have since emerged of cases in various other countries around the world. In adults, a similar condition has occasionally been reported, which has been called multisystem inflammatory syndrome in adults (MIS-A). Name
The disorder has been called by various names, including:

Multisystem inflammatory syndrome in children (MIS-C)
Multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19
Paediatric inflammatory multisystem syndrome (PIMS)
Paediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 infection (PIMS-TS)
Paediatric multisystem inflammatory syndrome (PMIS)
Kawa-COVID-19
Systemic inflammatory syndrome in COVID-19 (SISCoV)

Background
Symptomatic cases of COVID-19 in children have been relatively uncommon, possibly because they generally experience milder disease. Early infection tends to be associated with mild or no symptoms, while the later pulmonary phase, which can be life-threatening in adults, is usually mild or absent. While cases of children with severe symptoms are exceptional, they can occasionally require intensive care.
Acral persistent papular mucinosis is a skin condition caused by fibroblasts producing abnormally large amounts of mucopolysaccharides, characterized by bilaterally symmetrical, flesh-colored papules localized to the hands and wrists. : 185

See also
Papular mucinosis
List of cutaneous conditions

References


== External links ==